Oxytocin effects on the cognition of women with postpartum depression: A randomized, placebo-controlled clinical trial

What Was Tested

Researchers studied Oxytocin in this randomized controlled trial publication.

Few studies have assessed its therapeutic potential in PPD.

Who Took Part

PubMed indexes the participants as infants and adults, women only.

Participants completed a static task of FER of baby faces and a questionnaire of post-natal negative thoughts.

How the Study Was Run

In design terms this was a randomized, double-blind, placebo-controlled and crossover study.

The participants were allocated by chance, so the Oxytocin group and the comparison group should start out alike.

Blinding on both sides kept the participants and researchers unaware of who received Oxytocin.

Some participants received a placebo instead of Oxytocin, giving a reference point.

In the crossover set-up each of the participants took both Oxytocin and the comparison in turn, acting as their own control.

The researchers conducted a randomized double-blind, placebo-controlled trial with a crossover design involving mothers with PPD (N = 20) and without PPD (N = 35) in the puerperium.

What Was Measured

Few studies have assessed its therapeutic potential in PPD.

PubMed files the paper under topics including Cognition, Depression, Postpartum, Facial Recognition, Maternal Behavior, Oxytocin, Postpartum Period and Social Behavior.

Author keywords: Facial emotion recognition, Negative thoughts and Postpartum depression.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Oxytocin.

The abstract goes on to report its results in about 3 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2021 (Progress in neuro-psychopharmacology & biological psychiatry), a journal based in England.

More context: the Oxytocin compound page, all human trials.